Ambuja Cements (AMBUJACEM) — Corporate Action

Ambuja Cements convened a shareholders' meeting on November 20, 2025, to approve a Scheme of Arrangement with Sanghi Industries Limited under NCLT direction. The scheme involves amalgamation of Sanghi (Ambuja's 58.08% subsidiary) with Ambuja, resulting in a 12:100 share exchange ratio (12 Ambuja shares of ₹2 each for every 100 Sanghi shares of ₹10 each). Two independent valuers and merchant bankers confirmed the ratio as fair. The merger aims to integrate 6.1 MMTPA cement and 6.6 MMTPA clinker capacity in Kutch, achieving operational efficiencies and economies of scale. Remote e-voting occurred November 15–19, 2025; results announced November 22, pending final NCLT approval.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AMBUJACEM ✨ Ask AI About This

About Ambuja Cements Limited (AMBUJACEM)

Construction Materials · Cement & Cement Products · Listed on NSE

Market Cap: ₹1,07,215.34 Cr P/E: 23.3 ROE: 7.7% ROCE: 4.6%

View full AMBUJACEM stock details →

📡 Get AI alerts when AMBUJACEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AMBUJACEM — Free

💡 Ask AI about this filing

"How does this corporate action affect Ambuja Cements Limited's outlook?" "What did Ambuja Cements Limited announce on 14 October 2025?" "Is this positive or negative for AMBUJACEM?"

Ask AI Free →

📊 More AMBUJACEM filings

See all AMBUJACEM filings →

🔥 Also filed on 14 October 2025

AXISBANK Axis Bank Limited Corporate Action CHOLAFIN Cholamandalam Investment and Finance Company Limited Corporate Action TECHM Tech Mahindra Limited Financial Results TECHM Tech Mahindra Limited Corporate Action TECHM Tech Mahindra Limited Corporate Action COALINDIA Coal India Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AMBUJACEM files new disclosures

Track AMBUJACEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.